Lewis Joseph's Form 4 filing
iTeos Therapeutics, Inc. (ITOS) · filed Mar 18, 2022
- Accession no.
- 0000899243-22-011657
- Filed
- Mar 18, 2022, 9:00 PM ET
- Trade date
- Mar 17, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $20.3M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lewis JosephCIK 0001015747 | 10% Owner |
| Boxer Asset Management Inc.CIK 0001465836 | 10% Owner |
| Boxer Capital, LLCCIK 0001465837 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 | Common Stock | SSaleDisposed | −575,201 | $35.25 | −$20,275,835.25 | 3,142,058 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.